Compare LMB & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMB | PLSE |
|---|---|---|
| Founded | 1901 | 2014 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2014 | 2015 |
| Metric | LMB | PLSE |
|---|---|---|
| Price | $102.71 | $20.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $116.67 | $22.00 |
| AVG Volume (30 Days) | 164.9K | ★ 225.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.68 | N/A |
| EPS | ★ 3.23 | N/A |
| Revenue | ★ $646,804,000.00 | N/A |
| Revenue This Year | $15.96 | $840.00 |
| Revenue Next Year | $5.90 | $287.54 |
| P/E Ratio | $31.69 | ★ N/A |
| Revenue Growth | ★ 24.68 | N/A |
| 52 Week Low | $65.08 | $12.56 |
| 52 Week High | $154.04 | $26.30 |
| Indicator | LMB | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 43.43 |
| Support Level | $101.01 | $17.32 |
| Resistance Level | $128.57 | $20.40 |
| Average True Range (ATR) | 5.16 | 1.39 |
| MACD | 0.67 | -0.30 |
| Stochastic Oscillator | 94.28 | 12.82 |
Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.